Cencora, Inc. (COR)
NYSE: COR · Real-Time Price · USD
361.14
-0.50 (-0.14%)
Nov 19, 2025, 10:43 AM EST - Market open
Cencora Revenue
In the fiscal year ending September 30, 2025, Cencora had annual revenue of $321.33B with 9.31% growth. Cencora had revenue of $83.73B in the quarter ending September 30, 2025, with 5.92% growth.
Revenue (ttm)
$321.33B
Revenue Growth
+9.31%
P/S Ratio
0.22
Revenue / Employee
$6,985,496
Employees
46,000
Market Cap
70.02B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 321.33B | 27.37B | 9.31% |
| Sep 30, 2024 | 293.96B | 31.79B | 12.12% |
| Sep 30, 2023 | 262.17B | 23.59B | 9.89% |
| Sep 30, 2022 | 238.59B | 24.60B | 11.50% |
| Sep 30, 2021 | 213.99B | 24.09B | 12.69% |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
COR News
- 11 days ago - Cencora: Earnings Visibility Driving Re-Rating Potential - Seeking Alpha
- 13 days ago - Cencora, Inc. (COR) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 14 days ago - Cencora to invest $1 billion on US drug distribution, posts upbeat 2026 forecast - Reuters
- 14 days ago - Drug Distributor Cencora to Invest $1 Billion in U.S. Supply Chain - WSJ
- 14 days ago - Cencora Announces $1 Billion Investment to Strengthen Its U.S. Distribution Network - Business Wire
- 14 days ago - Cencora Reports Fiscal 2025 Fourth Quarter and Fiscal Year End Results - Business Wire
- 17 days ago - ADP, Snap-on Lead 14 Companies To Announce Annual Increases In First Half Of November - Seeking Alpha
- 4 weeks ago - IntrinsiQ Specialty Solutions Expands Data Capabilities to Empower Biopharmaceutical Manufacturers and Physicians with Actionable Insights to Improve Patient Outcomes - Business Wire